OTC · IMVIF
IMV Inc.
$0.00$0.00 (0.0%)
IMV Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · RGBOQ · USD
Stock price, earnings
Quote as of Oct 28, 2021, 07:28 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow ReGen Biologics Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
ReGen Biologics Inc., established in 1987 and headquartered in Hackensack, New Jersey, specialized in the development, manufacturing, and commercialization of medical devices. These devices were engineered for the restoration and growth of soft human tissues, particularly within orthopedic fields. The company's core asset was its unique collagen matrix technology, which found broader utility across various medical disciplines including general surgery, spinal care, cardiovascular applications, and drug delivery. Key product offerings included the Menaflex collagen meniscus implant, designed for reinforcing and repairing soft tissue damage to the medial meniscus during surgery, and the SharpShooter Tissue Repair System, an instrument that assisted surgeons in accurately placing needles in difficult-to-access meniscus regions. ReGen Biologics distributed its products internationally to countries such as the United States, the European Union, South Africa, Canada, Australia, Chile, and Japan. Originally named Aros Corp, the company adopted the ReGen Biologics Inc. moniker in November 2002. Facing financial challenges, ReGen Biologics Inc. filed for Chapter 11 bankruptcy on April 8, 2011, in the U.S. Bankruptcy Court for the District of Delaware, ultimately leading to a Chapter 11 liquidation approved on October 14, 2011.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:48 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$0.00$0.00 (0.0%)
IMV Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00+$0.00 (+40,113.65%)
Indie Ranch Media, Inc.: Healthcare · Medical - Care Facilities.
$0.00-$0.00 (-99.0%)
Allena Pharmaceuticals, Inc.: Healthcare · Biotechnology.
$0.00$0.00 (0.0%)
TGC Ventures International, Inc.: Healthcare · Medical - Distribution.
$59.00-$0.23 (-0.39%)
Taisho Pharmaceutical Holdings Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 1.67% below the high.
$0.00$0.00 (0.0%)
Photoelectron Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Green Hygienics Holdings Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00-$0.00 (-90.0%)
LifeHOUSE Holdings, LLC’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
